Column: Here’s why the arguments against canceling student debt make no sense

Motley Fool

Moderna Just Made a $700,000 Mistake

Moderna (NASDAQ: MRNA) is having a terrific year, raking in profits and generating plenty of cash due to its COVID-19 vaccine. As its business grows and the company plans for a post-COVID future, it needs to make smart decisions with its money. On May 9, Jorge Gomez was set to become Moderna’s CFO, replacing David Meline, who is planning to retire.

Leave A Reply

Your email address will not be published.